Lake Street Advisors Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lake Street Advisors Group's BMY Position: Q4 2024 in Review
Lake Street Advisors Group increased its Bristol-Myers Squibb (BMY) stake by 20% in Q4 2024, buying an estimated $140K and bringing the position to 14,722 shares worth $833K. The position accounts for 0.04% of the portfolio, ranked #247.
Lake Street Advisors Group first reported a position in BMY in Q4 2017 and has held it in 25 quarters since. The position peaked at $966K in Q4 2022. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Lake Street Advisors Group held 14,722 shares of Bristol-Myers Squibb worth $833K as of Q4 2024.
- Lake Street Advisors Group bought 2,498 Bristol-Myers Squibb shares in Q4 2024, an estimated $140K.
- Bristol-Myers Squibb made up 0.04% of Lake Street Advisors Group's portfolio in Q4 2024, its #247 holding.
- Lake Street Advisors Group first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 25 quarters since.
- Lake Street Advisors Group's Bristol-Myers Squibb position peaked at $966K in Q4 2022.
- 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Lake Street Advisors Group's 13F filing for Q4 2024, filed 4 Feb 2025.